secwatch.observer — SEC 8-K summary
======================================

Issuer:     Curanex Pharmaceuticals Inc (CURX)
CIK:        0002025942
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001493152-25-012404
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Curanex Pharmaceuticals closes IPO of 3.75M shares at $4.00, raising $15M gross
-------------------------------------------------------------------------------

- Gross proceeds of $15M from IPO of 3,750,000 shares at $4.00 per share on firm commitment basis.
- Net proceeds approximately $12.1M after underwriting discounts and estimated offering expenses.
- Common stock began trading on Nasdaq Capital Market on Aug 26, 2025 under ticker CURX.
- Underwriters granted 45-day option to purchase up to 562,500 additional shares at $4.00 per share.
- Lead underwriter Dominari Securities LLC; co-underwriters Pacific Century Securities LLC and Revere Securities LLC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2025942/000149315225012404/0001493152-25-012404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2025942/000149315225012404/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer